Advertisement
Policy Forum

Policy Forum Policy Forum articles provide a platform for health policy makers from around the world to discuss the challenges and opportunities in improving health care to their constituencies.

See all article types »

Studies Needed to Address Public Health Challenges of the 2009 H1N1 Influenza Pandemic: Insights from Modeling

  • Maria D. Van Kerkhove mail,

    m.vankerkhove@imperial.ac.uk

    Affiliation: MRC Centre for Outbreak Analysis and Modelling, Imperial College London, United Kingdom

    X
  • Tommi Asikainen,

    Affiliation: European Centre for Disease Prevention and Control

    X
  • Niels G. Becker,

    Affiliation: National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia

    X
  • Steven Bjorge,

    Affiliation: World Health Organization

    X
  • Jean-Claude Desenclos,

    Affiliation: Institut de Veille Sanitaire, Saint Maurice, France

    X
  • Thais dos Santos,

    Affiliation: World Health Organization

    X
  • Christophe Fraser,

    Affiliation: MRC Centre for Outbreak Analysis and Modelling, Imperial College London, United Kingdom

    X
  • Gabriel M. Leung,

    Affiliation: Food and Health Bureau, Government of Hong Kong SAR, Hong Kong SAR

    X
  • Marc Lipsitch,

    Affiliation: Center for Communicable Disease Dynamics and Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America

    X
  • Ira M. Longini Jr,

    Affiliations: Center for Statistics and Quantitative Infectious Disease (CSQUID), Vaccine and Infectious Diseases Institute, Hutchinson Research Center, Seattle, Washington, United States of America, Department of Biostatistics, University of Washington, School of Public Health, Seattle, Washington, United States of America

    X
  • Emma S. McBryde,

    Affiliation: Victorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, Victoria, Australia

    X
  • Cathy E. Roth,

    Affiliation: World Health Organization

    X
  • David K. Shay,

    Affiliation: Influenza Division, US Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

    X
  • Derek J. Smith,

    Affiliations: Department of Zoology, University of Cambridge, Cambridge, United Kingdom, Erasmus Medical Center, Department of Virology, Rotterdam, The Netherlands, Fogarty International Center, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Jacco Wallinga,

    Affiliations: National Institute of Public Health and the Environment (RIVM), Centre for Infectious Disease Control, Bilthoven, The Netherlands, University Medical Center Utrecht, Division Julius Center for Health Sciences and Primary Care, Utrecht, The Netherlands

    X
  • Peter J. White,

    Affiliations: MRC Centre for Outbreak Analysis and Modelling, Imperial College London, United Kingdom, Modelling and Economics Unit, Health Protection Agency Centre for Infections, London, United Kingdom

    X
  • Neil M. Ferguson,

    Affiliation: MRC Centre for Outbreak Analysis and Modelling, Imperial College London, United Kingdom

    X
  • Steven Riley,

    Affiliation: School of Public Health and Department of Community Medicine, The University of Hong Kong, Hong Kong SAR

    X
  • for the WHO Informal Network for Mathematical Modelling for Pandemic Influenza H1N1 2009 (Working Group on Data Needs)
  • Published: June 01, 2010
  • DOI: 10.1371/journal.pmed.1000275

About the Authors

Maria D. Van Kerkhove, Christophe Fraser, Peter J. White, Neil M. Ferguson
MRC Centre for Outbreak Analysis and Modelling, Imperial College London, United Kingdom
Tommi Asikainen
European Centre for Disease Prevention and Control
Niels G. Becker
National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia
Steven Bjorge, Thais dos Santos, Cathy E. Roth
World Health Organization
Jean-Claude Desenclos
Institut de Veille Sanitaire, Saint Maurice, France
Gabriel M. Leung
Food and Health Bureau, Government of Hong Kong SAR, Hong Kong SAR
Marc Lipsitch
Center for Communicable Disease Dynamics and Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America
Ira M. Longini Jr
Center for Statistics and Quantitative Infectious Disease (CSQUID), Vaccine and Infectious Diseases Institute, Hutchinson Research Center, Seattle, Washington, United States of America
Ira M. Longini Jr
Department of Biostatistics, University of Washington, School of Public Health, Seattle, Washington, United States of America
Emma S. McBryde
Victorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, Victoria, Australia
David K. Shay
Influenza Division, US Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
Derek J. Smith
Department of Zoology, University of Cambridge, Cambridge, United Kingdom
Derek J. Smith
Erasmus Medical Center, Department of Virology, Rotterdam, The Netherlands
Derek J. Smith
Fogarty International Center, National Institutes of Health, Bethesda, Maryland, United States of America
Jacco Wallinga
National Institute of Public Health and the Environment (RIVM), Centre for Infectious Disease Control, Bilthoven, The Netherlands
Jacco Wallinga
University Medical Center Utrecht, Division Julius Center for Health Sciences and Primary Care, Utrecht, The Netherlands
Peter J. White
Modelling and Economics Unit, Health Protection Agency Centre for Infections, London, United Kingdom
Steven Riley
School of Public Health and Department of Community Medicine, The University of Hong Kong, Hong Kong SAR

Corresponding Author

Email: m.vankerkhove@imperial.ac.uk

Competing Interests

PJW is a member of the UK government's Scientific Advisory Group for Emergencies (SAGE) and Scientific Pandemic Influenza Advisory Committee (SPI) and its modelling sub-group (SPI-M). He is employed by the UK Health Protection Agency. ML has received consulting fees from the Avian/Pandemic Flu Registry (Outcome Sciences), which is funded in part by Roche. ML has received consulting from Novartis Vaccines and Diagnostics. All other authors report no competing interests.

Author Contributions

ICMJE criteria for authorship read and met: MDVK TA NGB SB JCD TdS CF GML ML IMLJ ESM CER DKS DJS JW PJW NMF SR. Agree with the manuscript's results and conclusions: MDVK TA NGB SB JCD TdS CF GML ML IMLJ ESM CER DKS DJS JW PJW NMF SR. Wrote the first draft of the paper: MDVK TA SR. Contributed to the writing of the paper: MDVK TA NGB SB JCD TdS CF GML ML IMLJ ESM CER DKS DJS JW PJW NMF SR. Contributed to the discussion that led to the paper, helped to draft sections of the paper, and reviewed the final manuscript: TA NGB DJS. Involved in discussions that led to the paper: TdS. Contributed to design of content, drafted section of paper, reviewed paper: ESM. Involved in discussions that lead to the paper; helped define target audience and intended impact: CER. Suggested the topic: NMF.